Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single-Center, Feasibility Study Assessing the Safety and Performance of the Multi-Modal UltraSound Tomography (MUST) Device in Identifying Malignant Breast Lesions as an Adjunct to Mammography

NCT04102722 is registered in ClinicalTrials.gov with Transonic Imaging, Inc. as lead sponsor.

NCT NCT04102722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04102722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single-Center, Feasibility Study Assessing the Safety and Performance of the Multi-Modal UltraSound Tomography (MUST) Device in Identifying Malignant Breast Lesions as an Adjunct to Mammography
Lead sponsor
Transonic Imaging, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
January 14, 2020
Completion date
November 30, 2021
Enrollment
1,333 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer screening